These are severe and disabling conditions that require treatment by specialised professionals.
In part, our work is aimed at neurodegenerative disorders, which occur when nerve cells in the brain or peripheral nervous system lose their function over time, for example, Parkinson’s disease or amyotrophic lateral sclerosis.
We also address functional neurological disorders, which generate seizure episodes and uncontrolled electrical activity in the brain, such as epilepsy.
Our lines of research
Vascular and interstitial lung diseases
These are severe pathologies with low prevalence that require treatment by specialised professionals.
Pulmonary vascular diseases affect the blood vessels in the lungs, such as pulmonary hypertension.
Interstitial lung disease, on the other hand, refers to a group of disorders characterised by inflammation and fibrosis of the lung parenchyma, especially the connective tissue and alveolar walls.
What do we bring to the table?
We ensure the safety, quality and efficacy of our medicinal products
At Ferrer, people are always our central focus
That’s why your safety is our highest priority.
As a pharmaceutical company, our medicinal products meet strict quality, safety and efficacy requirements.
Ferrer believes that it is essential to work closely with all the stakeholders in the sector, including patients and their associations, caregivers and health professionals, among others.
By working together, we give all these stakeholders the power to transform patients’ healthcare experience.